|
|
| | Apigenin 7-O-methylglucuronide Basic information |
| Product Name: | Apigenin 7-O-methylglucuronide | | Synonyms: | Apigenin 7-O-methylglucuronide;(2S,3S,4S,5R,6S)-Methyl 3,4,5-trihydroxy-6-((5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chroMen-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylate;β-D-Glucopyranosiduronic acid, 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl, methyl ester;Apigenin-7-O-β-D-glucuronidemethylester | | CAS: | 53538-13-9 | | MF: | C22H20O11 | | MW: | 460.39 | | EINECS: | | | Product Categories: | | | Mol File: | 53538-13-9.mol |  |
| | Apigenin 7-O-methylglucuronide Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | powder | | color | Yellow |
| | Apigenin 7-O-methylglucuronide Usage And Synthesis |
| Description | Apigenin 7-O-methylglucuronide did not affect GAG level or secretion, may potentially be used in osteogenesis imperfecta (OI) type I pharmacotherapy in patients with normal GAG content.
Apigenin 7-O-methylglucuronide which normalized collagen synthesis in OI cells may exert their effects through beta1-integrin-mediated signaling. |
| | Apigenin 7-O-methylglucuronide Preparation Products And Raw materials |
|